Yüklüyor......
The cost-effectiveness of biopharmaceuticals: A look at the evidence
Due to the increasing availability and costs of biopharmaceuticals, policymakers are questioning whether they provide good value relative to other health interventions and many are increasingly relying on cost-utility analyses (CUAs) to supplement decision-making. Analyzing data from the Tufts Medic...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Landes Bioscience
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3361664/ https://ncbi.nlm.nih.gov/pubmed/22377753 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/mabs.4.2.18812 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|